Drugs News and Research

RSS

Researchers design modeling system to infer relationships between genes, drugs, and their environment

A team of researchers at the Icahn School of Medicine at Mount Sinai and the University of Washington has designed a modeling system that integrates genomic and temporal information to infer causal relationships between genes, drugs, and their environment, allowing for a more accurate prediction of their interactions over time.

11 Oct 2018

New molecular switch may help develop sophisticated photomedications

Light-activated switches are too small to be seen by the naked eye, but the molecular systems are hard at work in research related to drug design, adaptive materials and data storage.

11 Oct 2018

Otago scientists make a breakthrough in monkey malaria research

A breakthrough in monkey malaria research by University of Otago scientists encouraged the Bill & Melinda Gates Foundation to fund a special meeting in Dunedin recently.

11 Oct 2018

Technology-based positive psychology exercises improve quality of life in kidney dialysis patients

Kidney dialysis patients who engage in technology-based positive psychology exercises during their treatments may significantly improve their depressive symptoms and quality of life, a new study found.

11 Oct 2018

Young adults shying away from alcohol

A new study has found that more young adults in England, aged between 16 and 24 are turning away from alcohol consumption and this has made the current generation one of the most sober in recent times. The study was published in the recent issue of the journal BMC Public Health.

11 Oct 2018

Molecular mechanisms behind therapeutic action of ancient herbal medicine discovered

Researchers in the Department of Physiology & Biophysics at the University of California, Irvine School of Medicine have discovered the molecular basis for a therapeutic action of an ancient herbal medicine used across Africa to treat various illnesses, including epilepsy.

10 Oct 2018

Chromosomal instability may predict which patients will respond better to colorectal cancer drug

Researchers at RCSI, along with international collaborators within the ANGIOPREDICT research consortium, have discovered that chromosomal instability (where whole human chromosomes or parts of chromosomes are duplicated or deleted) may predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin).

10 Oct 2018

Using nanotechnology to fight dementia

In the human brain, nerve cells - so-called neurons - care for the transmission of electrical signals. They form the functional component responsible for sensations, stimuli and memories. In the presence of dementia, there is an adsorption of proteins outside the neurons, which then leads to the death of the neuronal cells. How to prevent the death of neurons is still the subject of scientific research today.

10 Oct 2018

Synedgen announces market launch of Moisyn Rinse for treatment of dry mouth symptoms

Synedgen, a company leveraging its proprietary glycomics technology platform to develop glycopolymer-based therapeutics for infectious and inflammatory conditions, today announced the market launch of Moisyn Rinse for the treatment of the symptoms of xerostomia, or dry mouth. Moisyn Rinse is being distributed by Prisyna, the oral care division of Synedgen.

10 Oct 2018

Molecular pathways underlying myopia open new ways for drug development

Myopia (nearsightedness) and hyperopia (farsightedness) develop through different molecular pathways, according to a new study publishing October 9 in the open-access journal PLOS Biology by Andrei Tkatchenko of Columbia University and colleagues.

10 Oct 2018

Antiepileptic drug use associated with elevated stroke risk in Alzheimer’s patients

Antiepileptic drug use is associated with an increased risk of stroke among persons with Alzheimer’s disease, according to a new study from the University of Eastern Finland. The risk did not differ between old and new antiepileptic drugs.

10 Oct 2018

Discovery of gene mutation could offer benefit for people suffering from diabetes, heart disease, obesity

Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.

10 Oct 2018

University of Houston biologist explores therapeutic targets to prevent atherosclerosis

University of Houston biologist Michihisa Umetani, having discovered that a certain protein partnership acts to rapidly signal molecules inside blood vessels that danger is upon them, has been awarded $382,500 by the National Institutes of Health.

10 Oct 2018

Bridge-like structure within estrogen receptor could serve as new drug target for breast cancer

Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis.

10 Oct 2018

Pioneering software system hopes to make epilepsy surgery safer and easier

A team of researchers, clinicians and engineers from UCLH, UCL, King's College London and the Epilepsy Society have developed a world-leading software system called EpiNav, which stands for epilepsy navigation, and their work is being featured on tonight's episode of the BBC's Trust Me I'm a Doctor.

10 Oct 2018

Brown researchers uncover new clues about ALS progression

Brown University researchers have uncovered new clues about the progression of Amyotrophic Lateral Sclerosis (ALS), a surprisingly common disease that causes the death of motor neurons that control voluntary muscles such as those involved in walking, talking, chewing or breathing.

10 Oct 2018

CDC’s Systemic Review analyzes HIV-related stigma among US healthcare providers

A Systemic Review from the U.S. Centers for Disease Control and Prevention analyzed studies of HIV-related stigma among healthcare provider and identified three main themes: attitudes, beliefs, and behaviors; quality of patient care; and education and training.

10 Oct 2018

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Sarcoma patients show great openness to the use of complementary alternative medicines (CAMs) for supportive care, but they are poorly informed about safety issues and risk of interactions with anti-cancer drugs, a study to be presented at ESMO 2018 reported.

10 Oct 2018

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Resistance to therapy is a major problem in cancer patients as the cells that resist to therapy is at the root of tumor relapse and is associated with high morbidity and mortality.

9 Oct 2018

Antibody Screening Tools; Improving Workflows

Antibody screening tools have exponentially increased the rate that candidates can be screened, multiplexing will increase processing to thousands per hour.¬

From Sartorius 9 Oct 2018

Drugs News and Research

Researchers design modeling system to infer relationships between genes, drugs, and their environment

New molecular switch may help develop sophisticated photomedications

Otago scientists make a breakthrough in monkey malaria research

Technology-based positive psychology exercises improve quality of life in kidney dialysis patients

Young adults shying away from alcohol

Molecular mechanisms behind therapeutic action of ancient herbal medicine discovered

Chromosomal instability may predict which patients will respond better to colorectal cancer drug

Using nanotechnology to fight dementia

Synedgen announces market launch of Moisyn Rinse for treatment of dry mouth symptoms

Molecular pathways underlying myopia open new ways for drug development

Antiepileptic drug use associated with elevated stroke risk in Alzheimer’s patients

Discovery of gene mutation could offer benefit for people suffering from diabetes, heart disease, obesity

University of Houston biologist explores therapeutic targets to prevent atherosclerosis

Bridge-like structure within estrogen receptor could serve as new drug target for breast cancer

Pioneering software system hopes to make epilepsy surgery safer and easier

Brown researchers uncover new clues about ALS progression

CDC’s Systemic Review analyzes HIV-related stigma among US healthcare providers

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Antibody Screening Tools; Improving Workflows

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News